Publications

Church J. Flat and depressed neoplasms of the colon in western populations (corrected). Am. J. Gastroentrol. 2006 Jul; 101 (7): 1676-7. Erratum in Am. J. Gastroenterol. 2006 Aug; 101 (8): 1944.

Lovegrove RE, Tilney HS, Heriot AG, von Roon AC, Athanasiou T, Church JM, Fazio VW, Tekkis PP. A Comparison of Adverse Events and Functional Outcomes After Restorative Proctocolectomy for Familial Adenomatous Polyposis and Ulcerative Colitis. Diseases of the Colon and Rectum. 2006 July 12 (Epub ahead of print)

Madbouly KM, Senagore AJ, Mukerjee A, Hussien AM, Shehata MA, Navine P, Delaney CP, Fazio VW. Colorectal cancer in a population with endemic Schistosoma mansoni: is this an at-risk population? Int. J. Colorectal Dis. 2006 Jun 20; (Epub ahead of print)

Stocchi L, Nelson H, Sargent DJ, Engen DE, Haddock MG. Is en bloc resection of locally recurrent rectal carcinoma involving the urinary tract indicated? Ann. Surg. Oncol.; 2006 May;13(5):740-4. Epub 2006 Mar 9.

Aziz O, Athanasiou T, Fazio VW, Nicholls RJ, Darzi AW, Church JM, Phillips RK, Tekkis PP. Meta-analysis of observational studies of ileorectal versus ileal pouch-anal anastomosis for familial adenomatous Polyposis. British Journal of Surgery; 2006 Apr;93(4):407-17.

Madbouly KM, Senagore AJ, Mukerjee A, Delaney CP, Connor J, Fazio VW. Does immunostaining effectively upstage colorectal cancer by identifying micrometastatic nodal disease? Int. J. Colorectal Disease; 2006 March 10 (epub ahead of print)

Lynch HT, Burke CA. Video Capsule Endoscopy: What is the role in surveillance of hereditary colon cancer syndromes? In: Markowitz, Guillem M. Techniques in Gastrointestinal Endoscopy.To be published January 2006

Stocchi L, Nelson H. Minimally invasive surgery for colorectal carcinoma. Ann. Surg. Oncol. 2005 Dec; 12(12):960-70.

Burke CA, Elder K, Lopez R. Screening for colorectal cancer with flexible sigmoidoscopy: Is a 5 year interval appropriate? A comparison of the detection of neoplasia 3 versus 5 years after a normal examination. Revision to the Am. J. Gastroenterology; November 2005

Heriot AG, Tekkis PP, Fazio VW, Neary P, Lavery IC. Adjuvant radiotherapy is associated with increased sexual dysfunction in male patients undergoing resection for rectal cancer: A predictive model. Ann. Surg.; 2005 Oct; 242(4):502-10, discussion 510-11.

Church JM. A Scoring System for the Strength of a Family History of Colorectal Cancer. Diseases of the Colon and Rectum; 2005 May;48(5):889-96.

Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, Terdiman JP, Conrad P, Moslein G, Goldberg R, Ziogas A, Anton-Culver H, de Andrade M, Siegmund K, Thibodeau SN, Boardman LA, Seminara D. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.[see comment]. [Journal Article] JAMA; 293(16):1979-85, 2005 Apr 27.

Madbouly KM, Remzi FH, Erkek AB, Senagore AJ, Baeslach CM, Khandwala F, Fazio VW, Lavery IC. Recurrence after transanal excision of T1 rectal cancer: should we be concerned? Diseases of the Colon and Rectum; 2005 Apr; 48(4):711-9; discussion 719-21.

Church JM et al. Practice Parameters for the Management of Rectal Cancer. Diseases of the Colon and Rectum; Volume 48, Issue 3, March 2005, pp. 411-423.

Casey G, Lindor NM, Papadopoulos N, Thibodeau SN, Moskow J, Steelman S, Buzin CH, Sommer SS, Collins CE, Butz M, Aronson M, Gallinger S, Barker MA, Young JP, Jass JR, Hopper JL, Diep A, Bapat B, Salem M, Seminara D, Haile R. Colon Cancer Family Registry. Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer. [Journal Article. Multicenter Study] JAMA 293(7):799-809, 2005 Feb 16.

Agarwal A, Das K, Lerner N, Sathe S, Cicek M, Casey G, Sizemore N. The AKT/I?B Kinase Pathway Promotes Angiogenic/Metastatic Gene Expression in Colorectal Cancer by Activating Nuclear Factor-?B and ß-catenin. Oncogene;2005 Feb 3;24(6):1021-31.

Oncel M, Church JM, Remzi FH, Fazio VW. Colonic Surgery in Patients with Juvenile Polyposis Syndrome: A Case Series. Diseases of the Colon and Rectum; 2005 January; 49 (1): 49-55; discussion 55-6.

Mackey R, Walsh M, Chung R, Brown N, Smith A, Church JM, Burke CA. Pancreas-sparing duodenectomy is effective management for familial adenomatous polyposis. J. Gastrointest. Surg.; 2005;9:1088-1093

Church JM. Ileoanal pouch neoplasia in familial adenomatous polyposis: an underestimated threat. Diseases of the Colon and Rectum; 48(9):1708-13, 2005.

Church JM, Berk T, Boman BM, Guillem J, Lynch C, Lynch P, Rodriguez-Bigas M, Rusin L, Weber T, Collaborative Group of the Americas on Inherited Colorectal Cancer. Staging intra-abdominal desmoid tumors in Familial Adenomatous Polyposis: a search for a uniform approach to a troubling disease. Diseases of the Colon and Rectum; 48(8):1528-34, 2005.

Burke CA. Juvenile Polyposis. In:Rossi B, Nakagawa W, et al eds. Cancer of the Colon, Rectum and Anus. Brasil: Tecmedd 2005:631-636.

Mackey R, Walsh M, Chung R, Brown N, Smith A, Church JM, Burke CA. Pancreas-sparing duodenectomy is effective management for familial adenomatous polyposis. J. Gastrointest. Surg. 2005;9:1088-1093

Robertson DJ, Greenberg ER, Beach M, Sandler R, Ahnen D, Haile R, Burke CA et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 2005;129:34-41

Robertson DJ, Burke CA, Schwender B et al. Histamine receptor antagonists and incident adenomas. Aliment Pharmacol. Ther. 2005;22:123-128

Burke CA, Santisi J, Church JM, Levinthal G. The utility of capsule endoscopy small bowel surveillance in patients with polyposis. Accepted: Am. J. Gastroenterology 2005;100:1498-1502

Burke CA. Colorectal Neoplasia. In Zein N, Lashner B, eds. The Year in Gastroenterology and Hepatology, Vol. 1.Clinical Publishing, Oxford, UK, 2005;71-84

Burke, CA. Colorectal Carcinoma. In: Stoller J, Ahmad M, Longworth eds.The Cleveland Clinic Intensive Review of Internal Medicine. 4th edition. Philadelphia: Lippincott, William and Wilkins, 2005;738-745

Burke CA. Juvenile Polyposis. In:Rossi B, Nakagawa W, et al eds.Cancer of the Colon, Rectum and Anus.Brasil: Tecmedd 2005;631-636

Bakhru M, Burke CA, Lopez R. Does waiting 5 years after polypectomy increase the risk of detecting clinically significant neoplasia? Direct evidence for a 5 year post-polypectomy interval. Am. J. Gastroenterology 2005;100:S387 (A1063)

Burke CA, Elder K. Screening for colorectal cancer with flexible sigmoidoscopy: Is a 5 year interval appropriate? A comparison of the detection of neoplasia in individuals undergoing flexible sigmoidoscopy 3 versus 5 years after a normal examination. Gastroenterology 2005;128:A-160 (S992)

Burke CA, Issa M, Church JM. A nationwide survey of post-polypectomy surveillance colonoscopy: Too Many Too Soon! Gastroenterology 2005;128:A-566 (W966).

Walsh M, Mackey R, Chung R, Brown N, Smith A, Church JM, Burke CA. Pancreas sparing duodenectomy; Effective management for familial adenomatous polyposis. Familial Cancer 2005;4:40(F16)

Fay S, Shenal J, McGannon EA, Patrick D, Church JM, Burke CA, Clark B. A wallet sized card recording HNPCC surveillance and follow up: Patient’s first impressions. Familial Cancer 2005;4:7(F26)

Fay S, Church JM, McGannon EA, Patrick D, Shenal J , Burke CA, Clark B. The benefits of counseling in families likely to have HNPCC, and why the families don’t get it. Familial Cancer 2005;4:48(F28)

Peterson SK, Askins M, Watts B, Burke CA, Hasson H, et al. Family resiliency and functioning among families with APC-positive children. Familial Cancer 2005:4:49(F31)

Lynch P, Burke CA, Hawk E, et al. Colonoscopy in a phase I safety trial of celecoxib in children with FAP. Familial Cancer 2005;4:56(F42)

Burke CA, Lynch P, Phillips RK, et al. Considerations for maximizing randomization in chemoprevention trials in FAP. Familial Cancer 2005;4:76(P27)

Burke CA, Walsh M, Church JM. The recurrence of small bowel neoplasia after duodenectomy. Familial Cancer 2005;4:50(P28)

Burke CA, Hawk E, Eagle C, et al. Design and primary safety outcome in a phase I trial of celecoxib in children with FAP. Familial Cancer 2005;4:50(P29)